These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1989915)

  • 1. Tumor growth fraction in cervical carcinoma.
    Wong WS; McGuire LJ
    Gynecol Oncol; 1991 Jan; 40(1):48-54. PubMed ID: 1989915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of Ki-67 antigen expression with mitotic figure index and tumor grade in breast carcinomas using the novel "paraffin"-reactive MIB1 antibody.
    Weidner N; Moore DH; Vartanian R
    Hum Pathol; 1994 Apr; 25(4):337-42. PubMed ID: 8163266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunohistochemical approach to reveal the growth potential of uterine cancers using anti-BrdU antibody and Ki-67].
    Yoshinouchi M
    Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2513-21. PubMed ID: 2614188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of proliferation-associated antigens in cervical carcinoma: correlations among indexes.
    Oka K; Nakano T; Arai T
    Pathol Res Pract; 1995 Oct; 191(10):997-1003. PubMed ID: 8838367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical detection of proliferating tumor cells in cervical cancer using monoclonal antibody Ki-67.
    Wong FW
    Gynecol Obstet Invest; 1994; 37(2):123-6. PubMed ID: 8150368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of response to radiation therapy of patients with cervical adenocarcinoma compared with squamous cell carcinoma. MIB-1 and PC10 labeling indices.
    Oka K; Nakano T; Hoshi T
    Cancer; 1996 Jun; 77(11):2280-5. PubMed ID: 8635096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoplasmic p105 index is an accurate mitotic index, but is not related to prognosis in cervical carcinoma.
    Oka K; Nakano T; Arai T
    Arch Pathol Lab Med; 1994 May; 118(5):506-9. PubMed ID: 7910727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential values of Ki-67 index and mitotic index of proliferating cell population. An assessment of cell cycle and prognosis in radiation therapy for cervical cancer.
    Nakano T; Oka K
    Cancer; 1993 Oct; 72(8):2401-8. PubMed ID: 8402456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoma of the cervix uteri: an assessment of the relationship of tumour proliferation to prognosis.
    Cole DJ; Brown DC; Crossley E; Alcock CJ; Gatter KC
    Br J Cancer; 1992 May; 65(5):783-5. PubMed ID: 1586610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferation indices in spontaneous canine lung cancer: proliferating cell nuclear antigen (PCNA), Ki-67 (MIB1) and mitotic counts.
    Griffey SM; Kraegel SA; Madewell BR
    J Comp Pathol; 1999 May; 120(4):321-32. PubMed ID: 10208729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of p53, Ki-67, and CD31 in the vaginal margins of radical hysterectomy in patients with stage IB carcinoma of the cervix.
    Silva-Filho AL; Traiman P; Triginelli SA; Reis FM; Pedrosa MS; Miranda D; Abreu ES; Macarenco RS; Cunha-Melo JR
    Gynecol Oncol; 2004 Dec; 95(3):646-54. PubMed ID: 15581977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical assessment of growth fractions in colorectal adenocarcinomas with monoclonal antibody Ki-67. Relation to clinical and pathological variables.
    Lanza G; Cavazzini L; Borghi L; Ferretti S; Buccoliero F; Rubbini M
    Pathol Res Pract; 1990 Oct; 186(5):608-18. PubMed ID: 2287588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody Ki-67 defined growth fraction in benign prostatic hyperplasia and prostatic cancer.
    Gallee MP; Visser-de Jong E; ten Kate FJ; Schroeder FH; Van der Kwast TH
    J Urol; 1989 Nov; 142(5):1342-6. PubMed ID: 2478729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of PCNA antigen in cellular proliferative activity of cervical carcinoma].
    Lenczewski A; Terlikowski S; Sulkowska M; Famulski W; Dobrzycka B; Sulkowski S; Musiatowicz B; Kulikowski M
    Ginekol Pol; 2000 Sep; 71(9):1164-8. PubMed ID: 11082996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitotic index and ki-67 nuclear antigen labeling index as predictors of chemotherapy response in uterine cervical carcinoma.
    Kamoi S; Ohaki Y; Okada S; Matsushita N; Kawamura T; Araki T
    Gynecol Oncol; 2001 Dec; 83(3):555-9. PubMed ID: 11733971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of cell proliferation in breast carcinoma. Comparison of Ki-67 immunohistochemical study, DNA flow cytometric analysis, and mitotic count.
    Isola JJ; Helin HJ; Helle MJ; Kallioniemi OP
    Cancer; 1990 Mar; 65(5):1180-4. PubMed ID: 2406010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of c-myc, epidermal growth factor receptor and c-erbB-2 in human endometrial carcinoma and cervical adenocarcinoma.
    Sato S; Ito K; Ozawa N; Yajima A; Sasano H
    Tohoku J Exp Med; 1991 Oct; 165(2):137-45. PubMed ID: 1687493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric and Ki-67 immunohistochemical analysis of cell cycle distribution of cervical cancer during radiation therapy.
    Higuchi KH; Nakano T; Tsuboi A; Suzuki Y; Ohno T; Oka K
    Anticancer Res; 2001; 21(4A):2511-8. PubMed ID: 11724315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ki67 index and S-phase fraction in human breast carcinomas. Comparison and correlations with prognostic factors.
    Vielh P; Chevillard S; Mosseri V; Donatini B; Magdelenat H
    Am J Clin Pathol; 1990 Dec; 94(6):681-6. PubMed ID: 2244589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient increases of growth fraction during fractionated radiation therapy for cervical carcinoma. Ki-67 and PC10 immunostaining.
    Oka K; Nakano T; Hoshi T
    Cancer; 1993 Nov; 72(9):2621-7. PubMed ID: 8402484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.